341 related articles for article (PubMed ID: 27863531)
1. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C
Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531
[TBL] [Abstract][Full Text] [Related]
2. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
[TBL] [Abstract][Full Text] [Related]
4. Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy.
Vaara S; Pettila V; Kaukonen KM
Acta Anaesthesiol Scand; 2012 Feb; 56(2):147-57. PubMed ID: 22092254
[TBL] [Abstract][Full Text] [Related]
5. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H
Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
Pea F; Viale P; Pavan F; Furlanut M
Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
[TBL] [Abstract][Full Text] [Related]
8. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
[TBL] [Abstract][Full Text] [Related]
9. Extended Daily Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury: A Meta-analysis.
Zhang L; Yang J; Eastwood GM; Zhu G; Tanaka A; Bellomo R
Am J Kidney Dis; 2015 Aug; 66(2):322-30. PubMed ID: 25843704
[TBL] [Abstract][Full Text] [Related]
10. Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
Dong H; Xie J; Chen L; Wang T; Sun J; Zhao Y; Dong Y
Int J Infect Dis; 2014 May; 22():35-40. PubMed ID: 24603161
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.
Awissi DK; Beauchamp A; Hébert E; Lavigne V; Munoz DL; Lebrun G; Savoie M; Fagnan M; Amyot J; Tétreault N; Robitaille R; Varin F; Lavallée C; Pichette V; Leblanc M
Pharmacotherapy; 2015 Jun; 35(6):600-7. PubMed ID: 26095008
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I
Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis.
Asín-Prieto E; Rodríguez-Gascón A; Trocóniz IF; Soraluce A; Maynar J; Sánchez-Izquierdo JÁ; Isla A
J Antimicrob Chemother; 2014 Jan; 69(1):180-9. PubMed ID: 23908259
[TBL] [Abstract][Full Text] [Related]
14. Con: Dialy- and continuous renal replacement (CRRT) trauma during renal replacement therapy: still under-recognized but on the way to better diagnostic understanding and prevention.
Honoré PM; Jacobs R; Joannes-Boyau O; De Waele E; Van Gorp V; Boer W; Spapen HD
Nephrol Dial Transplant; 2013 Nov; 28(11):2723-7; discussion 2727-8. PubMed ID: 24169609
[TBL] [Abstract][Full Text] [Related]
15. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review.
Chen H; Yu RG; Yin NN; Zhou JX
Crit Care; 2014 Dec; 18(6):675. PubMed ID: 25482187
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
[TBL] [Abstract][Full Text] [Related]
17. [Effect of continuous renal replacement therapy on the plasma concentration of imipenem in severe infection patients with acute renal injury].
Yu B; Liu L; Xing D; Zhao C; Hu Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):359-65. PubMed ID: 26003640
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
[TBL] [Abstract][Full Text] [Related]
19. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
[TBL] [Abstract][Full Text] [Related]
20. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.
Maseda E; Grau S; Villagran MJ; Hernandez-Gancedo C; Lopez-Tofiño A; Roberts JA; Aguilar L; Luque S; Sevillano D; Gimenez MJ; Gilsanz F
J Antimicrob Chemother; 2014 Jun; 69(6):1624-32. PubMed ID: 24505092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
